CombiMatrix Q2 Sales Rise 6 Percent on Prenatal Testing Demand
August 09, 2012
CombiMatrix Q2 Sales Rise 6 Percent on Prenatal Testing Demand
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CombiMatrix Q3 Revenues Rise as Focus Shifts to Prenatal Tests
November 7, 2012 / GenomeWeb Daily News - CombiMatrix Posts 36 Percent Increase in Q1 Revenues
May 11, 2012 / GenomeWeb Daily News - CombiMatrix Posts 20 Percent Q3 Revenue Gain
November 10, 2011 / GenomeWeb Daily News - Nasdaq Extends Deadline for CombiMatrix to Meet Listing Requirement
May 30, 2013 / GenomeWeb Daily News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News